Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ISET 25: FORWARD PAD IDE
Author(s): Daniel Clair Added: 3 months ago
ISET 2025 - Safety and efficacy outcomes of an intravascular lithotripsy (IVL) catheter used for the treatment of moderate to severely calcified lesions show a high ability to deliver the catheter with access to the lesion and very low rates of myocardial infarction and distal embolisation.Dr Daniel Clair (Vanderbilt University Medical Center, TN, US) joins us to discuss the key findings from the… View more

Intervention
Iatrogenic LIMA Dissection during Radial Artery Graft PCI
Author(s): Andrew Vanezis Added: 1 year ago

Intervention

Prevention & Chronic Conditions
Interventional Treatment of IHR-PE
Author(s): Federica Fumarola , Francesco Colombo , Claudio Corsaro , et al Added: 3 weeks ago

Heart Failure
Portrait image of Breanna Hansen
Job title: Cardiovascular Disease Fellow
Breanna is currently a cardiology fellow at Vanderbilt University Medical Center with a specific interest on cardiovascular health in women and cardio-obstetrics. She completed her medical training at the University of California, Riverside and internal medicine residency at Cedars Sinai Medical Center. She is passionate about medical education with a focus on curriculum development and… View more
Future Perspectives on Pulmonary Embolism Treatment
Author(s): Luca Franchin , Mario Iannaccone Added: 2 months ago

Intervention
New IVL Technologies for Calcified Tibial Artery Disease
Author(s): Andrew Holden Added: 1 month ago
What are the unique features of the new intravascular lithotripsy (IVL) devices addressing calcified tibial disease?Prof Andrew Holden (Auckland City Hospital, Auckland, NZ) joins us to discuss two new devices addressing calcified tibial disease, the Shockwave E8 catheter and the Shockwave Javelin catheter. Prof Holden then evaluates the safety and efficacy findings from the Disrupt PAD BTK II… View more

Intervention

Vascular Disease and Surgery
David Conen
Dr David Conen is a cardiologist, scientist and principal investigator at the Population Health Institute at McMaster University in Hamilton, Canada. Dr Conen is Principal Investigator of two major international trials studying the treatment and prevention of atrial fibrillation – the COP-AF and ASPIRE-AF Trials. View more
Research Area(s) / Expertise: Job title: MD
Dr Rafail Kotroniasis an Academic Cardiology Trainee at the Oxford Heart Centre and the Department of Cardiovascular Medicine, University of Oxford. He is aspiring to train as an interventional cardiologist with an interest in coronary artery and calcific aortic valve disease. His current research work focuses on invasive and non-invasive multimodality assessment of coronary artery disease… View more
ESC 24: The SCOFF Trial
Author(s): David Ferreira Added: 9 months ago
ESC Congress 24 — Fasting prior to cardiac catheterisation surgery significantly improves patient satisfaction score.We are joined onsite by Dr David Ferreira (John Hunter Hospital, AU) to discuss the findings from the SCOFF Trial (ACTRN12622001455752), which randomized 716 patients in a 1:1 fashion to either a no fasting group, or a fasting group. The fasting group were allowed solid foods 6… View more

Intervention
AHA 24: The OPTION Trial
Author(s): Oussama M Wazni Added: 6 months ago
AHA Conference 2024 - Safety and efficacy outcomes comparing left atrial appendage (LAA) closure with the WATCHMAN FLX device to oral anticoagulation (OAC) following atrial fibrillation (AF) catheter ablation.Dr Oussama Wazni (The Cleveland Clinic Foundation, Ohio, US) joins us onsite at AHA Conference to discuss the findings from OPTION (NCT03795298).OPTION is a prospective, multi-center, multi… View more

Anticoagulation

Electrophysiology & Arrhythmia